Literature DB >> 9879928

Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with Chronic Fatigue Syndrome.

A Vojdani1, P C Choppa, C Tagle, R Andrin, B Samimi, C W Lapp.   

Abstract

Mycoplasma fermentans and other Mycoplasma species are colonizers of human mucosal surfaces and may be associated with human immunodeficiency virus infection. While many infectious agents have been described in different percentages of patients with Chronic Fatigue Syndrome (CFS), little is known about the prevalence of mycoplasmas and especially M. fermentans in CFS patients. A polymerase chain reaction (PCR)-based assay was used to detect Mycoplasma genus and M. fermentans genomes in peripheral blood mononuclear cells (PBMC) of CFS patients. Blood was collected from 100 patients with CFS and 50 control subjects. The amplified products of 717 bp of Mycoplasma genus, and 206 bp of M. fermentans were detected in DNA purified from blood samples in 52% and 34% of CFS samples, respectively. In contrast, these genomes were found in only 14% and 8% of healthy control subjects respectively (P < 0.0001). All samples were confirmed by Southern blot with a specific probe based on internal sequences of the expected amplification product. Several samples, which were positive for Mycoplasma genus, were negative for M. fermentans indicating that other Mycoplasma species are involved. A quantitative PCR was developed to determine the number of M. fermentans genome copies present in 1 microg of DNA for controls and CFS patients. Mycoplasma copy numbers ranging from 130 to 880 and from 264 to 2400 were detected in controls and CFS positive subjects, respectively. An enzyme immunoassay was applied for the detection of antibodies against p29 surface lipoprotein of M. fermentans to determine the relationship between M. fermentans genome copy numbers and antibody levels. Individuals with high genome copy numbers exhibited higher IgG and IgM antibodies against M. fermentans specific peptides. Isolation of this organism by culture from clinical specimens is needed in order to demonstrate specificity of signal detected by PCR in this study.

Entities:  

Mesh:

Year:  1998        PMID: 9879928     DOI: 10.1111/j.1574-695X.1998.tb01226.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  22 in total

1.  Species-specific PCR for identification of common contaminant mollicutes in cell culture.

Authors:  F Kong; G James; S Gordon; A Zelynski; G L Gilbert
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

Review 2.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.

Authors:  James P Fabisiak; Fei Gao; Robyn G Thomson; Robert M Strieter; Simon C Watkins; James H Dauber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-02       Impact factor: 5.464

4.  Genome sequence of the repetitive-sequence-rich Mycoplasma fermentans strain M64.

Authors:  Hung-Wei Shu; Tze-Tze Liu; Huang-I Chan; Yen-Ming Liu; Keh-Ming Wu; Hung-Yu Shu; Shih-Feng Tsai; Kwang-Jen Hsiao; Wensi S Hu; Wailap Victor Ng
Journal:  J Bacteriol       Date:  2011-06-03       Impact factor: 3.490

5.  Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.

Authors:  Elina Parri; Heikki Kuusanmäki; Daria Bulanova; Satu Mustjoki; Krister Wennerberg
Journal:  Blood Adv       Date:  2021-04-13

Review 6.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Phenotypic Screening Combined with Machine Learning for Efficient Identification of Breast Cancer-Selective Therapeutic Targets.

Authors:  Prson Gautam; Alok Jaiswal; Tero Aittokallio; Hassan Al-Ali; Krister Wennerberg
Journal:  Cell Chem Biol       Date:  2019-05-02       Impact factor: 8.116

8.  Mycoplasma suppression of THP-1 Cell TLR responses is corrected with antibiotics.

Authors:  Ekaterina Zakharova; Jaykumar Grandhi; Mark D Wewers; Mikhail A Gavrilin
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

Review 9.  Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

10.  Microbial stimulation by Mycoplasma fermentans synergistically amplifies IL-6 release by human lung fibroblasts in response to residual oil fly ash (ROFA) and nickel.

Authors:  Fei Gao; Aaron Barchowsky; Antonia A Nemec; James P Fabisiak
Journal:  Toxicol Sci       Date:  2004-06-30       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.